Literature DB >> 1976210

Antitumor effects of somatostatin mediated by the stimulation of tyrosine phosphatase.

C Liebow1, M T Lee, A Schally.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 1976210     DOI： 10.1016/0026-0495(90)90237-7

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  9 in total

1.  Diagnosis and treatment of Cushing's syndrome. Cushing's syndrome: current clinical problems, symposium. Padova, October 19-20, 1990.

Authors: 
Journal:  J Endocrinol Invest       Date:  1992-03       Impact factor: 4.256

2.  Regulation of luteinizing hormone-releasing hormone receptor binding by heterologous and autologous receptor-stimulated tyrosine phosphorylation.

Authors:  C Liebow; M T Lee; A R Kamer; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

3.  Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors.

Authors:  M T Lee; C Liebow; A R Kamer; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

4.  Investigational Strategies for Detection and Intervention in Early-Stage Pancreatic Cancer. April 24-27, Annapolis, Maryland. Abstracts.

Authors: 
Journal:  Int J Pancreatol       Date:  1994 Oct-Dec

Review 5.  Somatostatin and the treatment of pancreatic cancer.

Authors:  G J Poston
Journal:  Ann R Coll Surg Engl       Date:  1994-05       Impact factor: 1.891

Review 6.  Signal transduction pathways: new targets in oncology.

Authors:  R K Sweeb; J H Beijnen
Journal:  Pharm World Sci       Date:  1993-12-17

7.  Transforming growth factor alpha is trophic to pancreatic cancer in vivo.

Authors:  N Davies; P Kapur; J Gillespie; P J Guillou; G J Poston
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

8.  Alterations in receptor-mediated kinases and phosphatases during carcinogenesis.

Authors:  D H Crean; C Liebow; M T Lee; A R Kamer; A V Schally; T S Mang
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

9.  Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.

Authors:  L Buscail; N Delesque; J P Estève; N Saint-Laurent; H Prats; P Clerc; P Robberecht; G I Bell; C Liebow; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.